Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance

Por Bailey, Tameka A., Luan, Haitao, Clubb, Robert J., Naramura, Mayumi, Band, Vimla, Raja, Srikumar M., Band, Hamid
Publicado em 2011

VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease

Por An, Wei, Mohapatra, Bhopal C., Zutshi, Neha, Bielecki, Timothy A., Goez, Benjamin T., Luan, Haitao, Iseka, Fany, Mushtaq, Insha, Storck, Matthew D., Band, Vimla, Band, Hamid
Publicado no Oncotarget (2016)

A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells

Por Bailey, Tameka A., Luan, Haitao, Tom, Eric, Bielecki, Timothy Alan, Mohapatra, Bhopal, Ahmad, Gulzar, George, Manju, Kelly, David L., Natarajan, Amarnath, Raja, Srikumar M., Band, Vimla, Band, Hamid
Publicado em 2014

Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene

Por Nadeau, Scott A., An, Wei, Mohapatra, Bhopal C., Mushtaq, Insha, Bielecki, Timothy A., Luan, Haitao, Zutshi, Neha, Ahmad, Gulzar, Storck, Matthew D., Sanada, Masashi, Ogawa, Seishi, Band, Vimla, Band, Hamid
Publicado no J Biol Chem (2017)

Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis

Por Ahmad, Gulzar, Mohapatra, Bhopal, Schulte, Nancy A., Nadeau, Scott, Luan, Haitao, Zutshi, Neha, Tom, Eric, Ortega-Cava, Cesar, Tu, Chun, Sanada, Masashi, Ogawa, Seishi, Toews, Myron L., Band, Vimla, Band, Hamid
Publicado no Int J Biochem Cell Biol (2014)

Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition

Por Raja, Srikumar M., Desale, Swapnil S., Mohapatra, Bhopal, Luan, Haitao, Soni, Kruti, Zhang, Jinjin, Storck, Matthew A., Feng, Dan, Bielecki, Timothy A., Band, Vimla, Cohen, Samuel M., Bronich, Tatiana K., Band, Hamid
Publicado no Oncotarget (2016)

Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer

Por Ortega-Cava, Cesar F., Raja, Srikumar M., Laiq, Zenab, Bailey, Tameka A., Luan, Haitao, Mohapatra, Bhopal, Williams, Stetson H., Ericsson, Aaron C., Goswami, Rasna, Dimri, Manjari, Duan, Lei, Band, Vimla, Naramura, Mayumi, Band, Hamid
Publicado em 2011

Polypeptide-based nanogels co-encapsulating a synergistic combination of Doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models

Por Desale, Swapnil S., Raja, Srikumar M., Kim, Jong Oh, Mohapatra, Bhopal, Soni, Kruti S., Luan, Haitao, Williams, Stetson H., Bielecki, Tim A, Feng, Dan, Storck, Matthew, Band, Vimla, Cohen, Samuel M., Band, Hamid, Bronich, Tatiana K.
Publicado no J Control Release (2015)

Loss of the nuclear pool of ubiquitin ligase CHIP/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program

Por Luan, Haitao, Mohapatra, Bhopal, Bielecki, Timothy A., Mushtaq, Insha, Mirza, Sameer, Jennings, Tameka A., Clubb, Robert J., An, Wei, Ahmed, Dena, Ansari, Rokaya El, Storck, Matthew D., Mishra, Nitish K., Guda, Chittibabu, Sheinin, Yuri M., Meza, Jane L., Raja, Srikumar, Rakha, Emad A., Band, Vimla, Band, Hamid
Publicado no Cancer Res (2018)